These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11025904)

  • 21. Pacemaker utilization during permanent atrial fibrillation in patients who received pacemaker implantation for sinus node dysfunction.
    Li H; Lakkireddy D; Korlakunta H; Rovang K; Hee T
    Am J Cardiol; 2005 Oct; 96(7):942-5. PubMed ID: 16188521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic atrial fibrillation and stroke in paced patients with sick sinus syndrome. Relevance of clinical characteristics and pacing modalities.
    Sgarbossa EB; Pinski SL; Maloney JD; Simmons TW; Wilkoff BL; Castle LW; Trohman RG
    Circulation; 1993 Sep; 88(3):1045-53. PubMed ID: 8353866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beneficial effects of losartan for prevention of paroxysmal atrial fibrillation in patients with sick sinus syndrome: analysis with memory function of pacemaker.
    Takii E; Inage T; Yoshida T; Ohe M; Gondo T; Haraguchi G; Ito S; Kumanomido J; Imaizumi T; Fukuomoto Y
    Heart Vessels; 2016 Mar; 31(3):402-7. PubMed ID: 25787020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacologic atrial defibrillation by drug delivery into the temporarily occluded coronary sinus. A canine study.
    Watanabe I; Okumura Y; Ohkubo K; Nagashima K; Sonoda K; Mano H; Kofune M; Hirayama A
    Int Heart J; 2012; 53(2):125-8. PubMed ID: 22688317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy and safety of a single oral dose of pilsicainide in supraventricular arrhythmia after coronary artery bypass grafting].
    Kohno K; Takeuchi Y; Gomi A; Nakatani H; Suda Y; Shimabukuro T; Nagano N
    Jpn J Thorac Cardiovasc Surg; 1998 Apr; 46(4):361-7. PubMed ID: 9619036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective randomized study to assess the efficacy of site and rate of atrial pacing on long-term progression of atrial fibrillation in sick sinus syndrome: Septal Pacing for Atrial Fibrillation Suppression Evaluation (SAFE) Study.
    Lau CP; Tachapong N; Wang CC; Wang JF; Abe H; Kong CW; Liew R; Shin DG; Padeletti L; Kim YH; Omar R; Jirarojanakorn K; Kim YN; Chen MC; Sriratanasathavorn C; Munawar M; Kam R; Chen JY; Cho YK; Li YG; Wu SL; Bailleul C; Tse HF;
    Circulation; 2013 Aug; 128(7):687-93. PubMed ID: 23868858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Termination of symptoms in the sick sinus syndrome by atrial fibrillation.
    Lister JW
    Pacing Clin Electrophysiol; 1978 Oct; 1(4):510-3. PubMed ID: 95644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pacing or ablation: which is better for paroxysmal atrial fibrillation-related tachycardia-bradycardia syndrome?
    Chen YW; Bai R; Lin T; Salim M; Sang CH; Long DY; Yu RH; Tang RB; Guo XY; Yan XL; Nie JG; Du X; Dong JZ; Ma CS
    Pacing Clin Electrophysiol; 2014 Apr; 37(4):403-11. PubMed ID: 24456243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atrial pacing failure following termination of atrial fibrillation by acute administration of disopyramide phosphate.
    Anzawa R; Ishikawa S; Tanaka Y; Okazaki F; Mochizuki S
    J Interv Card Electrophysiol; 2005 Jun; 13(1):51-3. PubMed ID: 15976979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of pilsicainide hydrochloride on atrial fibrillation threshold].
    Ishibashi K; Inoue D; Omori I; Shirayama T; Inoue M; Sakai R; Yamahara Y; Asayama J; Nakagawa M
    Kokyu To Junkan; 1993 Aug; 41(8):763-7. PubMed ID: 8351435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Biatrial stimulation in therapy of paroxysmal atrial tachycardia: a case report].
    Heisel A; Jung J; Neuzner J; Schieffer H; Fröhlig G
    Z Kardiol; 1997 Jul; 86(7):524-9. PubMed ID: 9340943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adverse effects of direct current cardioversion on cardiac pacemakers and electrodes Is external cardioversion contraindicated in patients with permanent pacing systems?
    Waller C; Callies F; Langenfeld H
    Europace; 2004 Mar; 6(2):165-8. PubMed ID: 15018877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Right versus left atrial pacing in patients with sick sinus syndrome and paroxysmal atrial fibrillation (Riverleft study): study protocol for randomized controlled trial.
    Ramdjan TT; van der Does LJ; Knops P; Res JC; de Groot NM
    Trials; 2014 Nov; 15():445. PubMed ID: 25403703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An open-label, single-dose, parallel-group, dose-increasing study comparing the pharmacokinetics and tolerability of pilsicainide hydrochloride in healthy Korean and Japanese male subjects.
    Kim BH; Kim JR; Lim KS; Kim JW; Kim KP; Hong JH; Jang IJ; Shin SG; Yu KS; Tanaka T
    Clin Ther; 2009 Mar; 31(3):609-18. PubMed ID: 19393851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural history of sinus node disease treated with atrial pacing in 213 patients: implications for selection of stimulation mode.
    Brandt J; Anderson H; Fåhraeus T; Schüller H
    J Am Coll Cardiol; 1992 Sep; 20(3):633-9. PubMed ID: 1512343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of pilsicainide on the atrial fibrillation threshold in guinea pig atria. A comparative study with disopyramide, lidocaine and flecainide.
    Inoue M; Inoue D; Ishibashi K; Sakai R; Omori I; Yamahara Y; Asayama J; Nakagawa M
    Jpn Heart J; 1993 May; 34(3):301-12. PubMed ID: 8411636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effective Management of Atrioventricular Interval for Paroxysmal Atrial Fibrillation That Developed After DDDR Pacemaker Implantation in a Sick Sinus Syndrome Patient.
    Tasaki H; Ashizawa N; Nagao S; Fukushima K; Furukawa R; Fukae S; Maemura K
    Int Heart J; 2015; 56(5):558-63. PubMed ID: 26370366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrophysiological determinants of atrial fibrillation in sinus node dysfunction despite atrial pacing.
    De Sisti A; Attuel P; Manot S; Fiorello P; Halimi F; Leclercq JF
    Europace; 2000 Oct; 2(4):304-11. PubMed ID: 11194597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dispersion of signal-averaged P wave duration on precordial body surface in patients with paroxysmal atrial fibrillation.
    Yamada T; Fukunami M; Shimonagata T; Kumagai K; Sanada S; Ogita H; Asano Y; Hori M; Hoki N
    Eur Heart J; 1999 Feb; 20(3):211-20. PubMed ID: 10082154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ischemia enhances use-dependent sodium channel blockade by pilsicainide, a class IC antiarrhythmic agent.
    Sadanaga T; Ogawa S
    J Am Coll Cardiol; 1994 May; 23(6):1378-81. PubMed ID: 8176096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.